Growth Metrics

Agilon Health (AGL) Gains from Investment Securities (2020 - 2025)

Agilon Health's Gains from Investment Securities history spans 6 years, with the latest figure at -$53000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 96.15% year-over-year to -$53000.0; the TTM value through Dec 2025 reached $5.5 million, up 722.1%, while the annual FY2025 figure was $5.5 million, 722.1% up from the prior year.
  • Gains from Investment Securities reached -$53000.0 in Q4 2025 per AGL's latest filing, down from $2.5 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $2.5 million in Q4 2023 to a low of -$1.8 million in Q1 2021.
  • Average Gains from Investment Securities over 5 years is $544650.0, with a median of $504500.0 recorded in 2023.
  • Peak YoY movement for Gains from Investment Securities: soared 2330.19% in 2022, then plummeted 203.18% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at $53000.0 in 2021, then skyrocketed by 2330.19% to $1.3 million in 2022, then skyrocketed by 96.66% to $2.5 million in 2023, then tumbled by 154.4% to -$1.4 million in 2024, then skyrocketed by 96.15% to -$53000.0 in 2025.
  • Per Business Quant, the three most recent readings for AGL's Gains from Investment Securities are -$53000.0 (Q4 2025), $2.5 million (Q3 2025), and $878000.0 (Q2 2025).